CML is a stem cell-driven myeloproliferative disorder that arises in a single haematopoietic stem cell (HSC) with the introduction of the BCR::ABL1 oncoprotein13. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.